Search research articles
Contact Us
Filters
Showing results (51-60 of 95) with videos related to
Page
of 10
Sort By:
Clinical Pharmacology and Therapeutics
|
June 1, 1978
Para-aminosalicylic acid as a lipid-lowering agent
B Vessby, H Lithell, J Boberg, et al.
Journal of the American Podiatric Medical Association
|
August 1, 1989
Lawrence design first metatarsophalangeal prosthesis. A complication
S A Hamilton, J Boberg, L A Gilula
Journal of Cataract and Refractive Surgery
|
November 1, 1989
Axial length following implantation of posterior chamber lenses
K Naeser, A Naeser, J Boberg-Ans, et al.
Lakartidningen
|
June 4, 1975
["Lipid research clinics"--a new concept in clinical atherosclerosis research]
J Boberg, M Boberg, C Furberg, et al.
Atherosclerosis
|
January 1, 1980
Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol
B Vessby, H Lithell, I B Gustafsson, et al.
International Journal of Andrology
|
March 21, 2012
Perinatal ethinyl oestradiol alters mammary gland development in male and female Wistar rats
K R Mandrup, U Hass, S Christiansen, et al.
Acta Medica Scandinavica
|
January 1, 1984
Serum lipoprotein and apolipoprotein concentrations in patients with hyperthyroidism and the effect of treatment with carbimazole
J Boberg, P A Dahlberg, B Vessby, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1987
Effects of diet fat P/S ratio on serum lipoprotein concentrations
J Boberg, C Berne, T Pollare, et al.
The Journal of Bone and Joint Surgery. American Volume
|
February 3, 2006
Hospital cost of dislocation after primary total hip arthroplasty
Joaquin Sanchez-Sotelo, George J Haidukewych, Carol J Boberg
Proceedings of the Royal Society of Medicine
|
January 1, 1976
Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial
B Vessby, H Lithell, J Boberg, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 95) with videos related to
Sort By:
Page
of 10
Clinical Pharmacology and Therapeutics
|
June 1, 1978
Para-aminosalicylic acid as a lipid-lowering agent
B Vessby, H Lithell, J Boberg, et al.
Journal of the American Podiatric Medical Association
|
August 1, 1989
Lawrence design first metatarsophalangeal prosthesis. A complication
S A Hamilton, J Boberg, L A Gilula
Journal of Cataract and Refractive Surgery
|
November 1, 1989
Axial length following implantation of posterior chamber lenses
K Naeser, A Naeser, J Boberg-Ans, et al.
Lakartidningen
|
June 4, 1975
["Lipid research clinics"--a new concept in clinical atherosclerosis research]
J Boberg, M Boberg, C Furberg, et al.
Atherosclerosis
|
January 1, 1980
Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol
B Vessby, H Lithell, I B Gustafsson, et al.
International Journal of Andrology
|
March 21, 2012
Perinatal ethinyl oestradiol alters mammary gland development in male and female Wistar rats
K R Mandrup, U Hass, S Christiansen, et al.
Acta Medica Scandinavica
|
January 1, 1984
Serum lipoprotein and apolipoprotein concentrations in patients with hyperthyroidism and the effect of treatment with carbimazole
J Boberg, P A Dahlberg, B Vessby, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1987
Effects of diet fat P/S ratio on serum lipoprotein concentrations
J Boberg, C Berne, T Pollare, et al.
The Journal of Bone and Joint Surgery. American Volume
|
February 3, 2006
Hospital cost of dislocation after primary total hip arthroplasty
Joaquin Sanchez-Sotelo, George J Haidukewych, Carol J Boberg
Proceedings of the Royal Society of Medicine
|
January 1, 1976
Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial
B Vessby, H Lithell, J Boberg, et al.
Page
of 10